DK249680A - Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner - Google Patents

Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner

Info

Publication number
DK249680A
DK249680A DK249680A DK249680A DK249680A DK 249680 A DK249680 A DK 249680A DK 249680 A DK249680 A DK 249680A DK 249680 A DK249680 A DK 249680A DK 249680 A DK249680 A DK 249680A
Authority
DK
Denmark
Prior art keywords
pyrroline
hydroxy
substituted
dione
preparing
Prior art date
Application number
DK249680A
Other languages
Danish (da)
English (en)
Inventor
E J Cragoe
C S Rooney
H W R Williams
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK249680A publication Critical patent/DK249680A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK249680A 1979-06-11 1980-06-10 Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner DK249680A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/047,413 US4256758A (en) 1979-06-11 1979-06-11 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Publications (1)

Publication Number Publication Date
DK249680A true DK249680A (da) 1980-12-12

Family

ID=21948829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK249680A DK249680A (da) 1979-06-11 1980-06-10 Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner

Country Status (10)

Country Link
US (1) US4256758A (enEXAMPLES)
EP (1) EP0021228B1 (enEXAMPLES)
JP (1) JPS562962A (enEXAMPLES)
AT (1) ATE1501T1 (enEXAMPLES)
DE (1) DE3060801D1 (enEXAMPLES)
DK (1) DK249680A (enEXAMPLES)
ES (1) ES492310A0 (enEXAMPLES)
GR (1) GR68727B (enEXAMPLES)
IE (1) IE49902B1 (enEXAMPLES)
PT (1) PT71368B (enEXAMPLES)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428959A (en) * 1980-04-04 1984-01-31 Merck & Co., Inc. 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
JPS5816528U (ja) * 1981-07-25 1983-02-01 三菱重工業株式会社 液位計
US4596821A (en) * 1984-05-01 1986-06-24 Merck & Co., Inc. Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4604403A (en) * 1984-05-01 1986-08-05 Merck & Co., Inc. Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4634717A (en) * 1984-05-01 1987-01-06 Merck & Co., Inc. Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
US4605664A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treatment of grey matter edema
US4605663A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, for treatment of grey matter edema
DE68921159T2 (de) * 1988-10-29 1995-07-06 Cadbury Schweppes Plc Netzmittel.
US6353128B1 (en) * 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
AU2005321946B2 (en) 2004-12-23 2012-08-16 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
AU2008242720A1 (en) 2007-04-20 2008-10-30 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
MX2011004535A (es) 2008-10-29 2011-11-18 Deciphera Pharmaceuticals Llc Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas.
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
RU2018138195A (ru) 2012-12-17 2018-12-18 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4- фенилбутил)карбамимидоил)пиразин-2-карбоксамида
AU2013363218B2 (en) 2012-12-17 2018-03-15 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
DE102013213217A1 (de) 2013-07-05 2015-01-08 Bayerische Motoren Werke Aktiengesellschaft Schließbaugruppe für einen Gepäckkoffer
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
EP3386967A4 (en) * 2015-12-07 2020-03-25 Wake Forest University Health Sciences COMBINATIONS FOR THE TREATMENT OF KIDNEY CALCULATIONS
CN107805209B (zh) * 2016-09-09 2020-11-10 中国石化扬子石油化工有限公司 一种对二乙酰苯酰胺化制备2-(4-氨基甲酰基甲基-苯基)-乙酰胺的方法
WO2019152711A1 (en) 2018-01-31 2019-08-08 Diciphera Pharmaceuticals Llc. Combination therapy for the treatment of gastrointestinal stromal tumors
BR112020015572A2 (pt) 2018-01-31 2021-02-02 Deciphera Pharmaceuticals, Llc terapia de combinação para o tratamento da mastocitose
CN114615982A (zh) 2019-08-12 2022-06-10 德西费拉制药有限责任公司 用于治疗胃肠道间质瘤的瑞普替尼
TWI878335B (zh) 2019-08-12 2025-04-01 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
IL293866A (en) 2019-12-30 2022-08-01 Deciphera Pharmaceuticals Llc Amorphous kinase inhibitor formulations and methods of use thereof
FI4084779T3 (fi) 2019-12-30 2024-12-16 Deciphera Pharmaceuticals Llc 1-(4-bromi-5-(1-etyyli-7-(metyyliamino)-2-okso-1,2-dihydro-1,6-naftyridin-3-yyli)-2-fluorifenyyli)-3-fenyyliurean koostumuksia
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184475A (en) * 1961-09-15 1965-05-18 Monsanto Co Maleimides, maleamides and fumaramides
US3183245A (en) * 1963-01-04 1965-05-11 Parke Davis & Co Process for the production of alpha-methyl-alpha-phenyl-beta-ethylsuccinimide
DE1445664A1 (de) * 1963-07-04 1969-11-27 Klinke Desitin Werk Verfahren zur Herstellung von alpha,alpha-disubstituierten Succinimiden
CH445487A (de) * 1963-08-05 1967-10-31 Calanda Stiftung Verfahren zur Darstellung cyclischer Imide
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
US3317390A (en) * 1965-07-27 1967-05-02 American Cyanamid Co Compositions having cns depressant activity

Also Published As

Publication number Publication date
US4256758A (en) 1981-03-17
PT71368B (en) 1981-10-21
IE801178L (en) 1980-12-11
ATE1501T1 (de) 1982-09-15
ES8105283A1 (es) 1981-05-16
EP0021228A1 (en) 1981-01-07
IE49902B1 (en) 1986-01-08
JPS562962A (en) 1981-01-13
DE3060801D1 (en) 1982-10-28
ES492310A0 (es) 1981-05-16
EP0021228B1 (en) 1982-09-01
PT71368A (en) 1980-07-01
GR68727B (enEXAMPLES) 1982-02-10

Similar Documents

Publication Publication Date Title
DK249680A (da) Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner
DK384280A (da) Fremgangsmaade til fremstilling af substituerede 4-thiazolyl-3-hydroxy-3-pyrrolin-2,5-dioner
ES529314A0 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
NO844656L (no) Dispergeringsmiddel for salthodige systemer
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3875796D1 (de) Kombiniertes verfahren zur thermischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural.
DE3854598D1 (de) Verfahren zur Herstellung von radialen, asymmetrischen Copolymeren.
NO853466L (no) Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
NO874550D0 (no) Fremgangsmaate for fremstilling av estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3(4h)-on og beslektede forbindelser.
FI882265A7 (fi) Menetelmä fruktosamiinin määrittämiseksi.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
DE3875797D1 (de) Kombiniertes verfahren zur thermischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural.
NO880592L (no) Herdbare harpikser, fremgangsmaate for fremstilling av disse og anvendelse av disse.
DE68918752D1 (de) Verfahren zur Herstellung von heterocyclischen Aldehyden.
DE3774715D1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE69018888D1 (de) Verfahren zur Herstellung von Imidazolidin-2,5-dion-Derivaten.
NO872765L (no) Beta-laktam-sammensetning, og framgangsmaate for framstilling av denne.
NO892171D0 (no) Fremgangsmaate for stabilisering, konsolidering og lagringav avfallsmaterialer.
DK103594A (da) Fremgangsmåde til fremstilling af benzoesyreforbindelser

Legal Events

Date Code Title Description
ATS Application withdrawn